CTOs on the Move

Greenway Medical Technologies, Inc.

www.greenwaymedical.com

 
Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions and services to 20000 healthcare providers and professionals nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Train for Compliance.

Train for Compliance. is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bayshore HealthCare

At Bayshore, we believe in creating special moments for our clients each and every day, whether at the bedside, on the phone or in the clinic. These moments touch the lives of our clients and our employees, and they guide the way we run our business. These moments inspire, change and encourage us. They are what we call the Bayshore difference. Bayshore HealthCare is one of the country`s leading providers of home and community health care services and is a Canadian-owned company.

Happier Living

Happier Living is the premier national outpatient private practice that is expanding access to mental health as an in-network organization. We`re a strong community of highly qualified and passionate clinicians focused on long-standing therapeutic relationships with our clients.

Amicus Therapeutics

Amicus Therapeutics, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Amicus Therapeutics, Inc. is based in Cranbury, NJ. You can find more information on Amicus Therapeutics, Inc. at www.amicustherapeutics.com

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.